These studies suggest that the recombinant rIHNV-Gvhsv GFP is a promising candidate to be used as an IHNV live recombinant vaccine and a good model to further study viral pathogenicity and the molecular bases of the protection against these infections.
In order to assess the potential of the recombinant viruses as vaccines against the wild type viruses, rainbow trout were vaccinated with them by intraperitoneal injection and challenged 30 days later with virulent IHNV or VHSV. The GFP viruses provided protection against both wild type viruses. None of the recombinant viruses induced antibody production and the expression of interferon (IFNαβ) and interferon induced genes such as Mx protein and ISG-15, was not different to those of controls. The rIHNV-Gvhsv GFP did not inhibit the cellular apoptosis as it was observed in an IHNV inoculated fish cell line.
These studies suggest that the recombinant rIHNV-Gvhsv GFP is a promising candidate to be used as an IHNV live recombinant vaccine and a good model to further study viral pathogenicity and the molecular bases of the protection against these infections. Rhabdoviridae family members. They have a single-stranded RNA genome that encodes five structural proteins (Morzunov et al. 1995 , Schütze et al. 1995 ) and a nonvirion protein NV (Kurath et al. 1985 , Schütze et al. 1996 .
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Due to the lack of effective strategies to control these diseases, IHNV and VHSV infections usually cause high mortalities. Although vaccination is the most suitable control method, there is only one available live attenuated vaccine for VHSV licensed in Germany since 1996 (P. Enzmann Tübingen) and a DNA IHNV vaccine licensed in Canada (Novartis). Moreover highly efficient IHNV and VHSV DNA vaccines have been developed (Anderson et al. 1996 , Heppell et al. 1998 and are being tested in field trials.
Reverse genetics have been recently used to generate modified rhabdoviruses that could be potential candidates to be used as live vaccines. Reverse genetics consists on the recovery of recombinant viruses from vaccinia-infected cells that are transfected with an expression plasmid coding for the full length antigenomic cDNA together with plasmids coding for the nucleoprotein (N), the phosphoprotein (P) and the RNA polymerase (L). This system has been applied to several rhabdoviral models (Schnell et Lawson et al. 1995 , Whelan et al. 1995 , Biacchesi et al. 2000 a, b, Johnson et al. 2000 , Ito et al. 2001 ).
The recombinant viruses used in the present study had two of the six IHNV genome genes modified. One encodes the G protein related with this virus pathogenicity and capable of eliciting protective antibody production against various IHNV strains (Engelking & Leong 1989 a, b) . The other is the NV protein whose function is not well known but it is able to enhance viral growth in cell culture (Kurath & Leong 1985) .
Changes in the viral genome might modify viral characteristics such as virulence and tissue tropism
The IHNV genome has been shown to be extremely flexible to accommodate heterologous structural proteins. The complete IHNV G gene has been replaced by the VHSV G gene, recovering a recombinant virus expressing the VHSV G instead of IHNV G (Biacchesi et al. 2002) . This virus was already shown to efficiently replicate in cell culture, and to be virulent for rainbow trout by bath infection. The replacement of the G protein by VHSV G protein (rIHNV-Gvhsv) did not modify the tropism or the lesions induced by viral infection (Romero et al. 2005 ). Kim et al. (1994) , using a mAb directed against the IHNV-G protein, selected a G-mutant strain, RB-1 particularly attenuated and related the loss of virulence with G protein amino acid changes at position 78 and 218 and probably with other changes in the viral genome (Romero et al. 2005) . As it was demonstrated by the successful recovery of recombinant virus expressing foreign genes instead of the NV gene, the NV In order to evaluate the recombinant viruses potential as a live attenuated vaccines, two recombinant IHN viruses were investigated and tested in a vaccine trial.
The recombinant virus rIHNV GFP, described by Biacchesi et al. (2000 a) , has never been tested in experimental infections and vaccine trials. Morevover, a new recombinant virus (generated for this paper) rIHNV-Gvhsv GFP similar to the rIHNVGvhsv described by Biacchesi et al. (2002) , in which the NV gene was replaced by the GFP gene, has been also assayed for the first time.
To the best of our knowledge, this is the first paper describing changes in the viral cycle, pathology and tissue tropism of both recombinant viruses. The protective response was characterized by determining antibody production, several antiviral genes expression levels and apoptosis induction. Viruses and cell cultures. Recombinant rIHNV GFP and rIHNV-Gvhsv GFP (Biacchesi et al. 2000 (Biacchesi et al. a, b, 2002 , were used in the present study. The non-structural NV gene was replaced with the green fluorescent protein (GFP) gene and the G protein gene was changed for that of VHSV in the rIHNV-Gvhsv GFP. The wild type (wt) virus strains used were French isolates IHNV 32/87 and the European VHSV 07-71 strain (Laurencin, 1987) .
Viruses were replicated in the EPC fish epithelial cell-line, derived from common carp (Cyprinus carpio L.) (Tomasec & Fijan 1971) and in the RTG-2 cell line derived from rainbow trout gonad tissue (Wolf & Quimby 1962) . Viral replication was carried out at 15ºC and the viral titer was calculated according to the protocol described by Reed and Müench (1938) . RTG-2 and EPC cell lines stocks were cultured in Eagle's minimum essential medium (MEM, Gibco) supplemented with 10% of foetal bovine serum (FBS), penicillin (100 IU ml -1 ), streptomycin (100 μg ml -1 ), buffered with 7.5% sodium bicarbonate and incubated at 20ºC. types were included and a negative control group was injected with culture medium.
External signs (nature and intensity) and mortalities were recorded every day for 30 days after virus exposure. Fish were also kept in 50 l tanks with a closed circuit water system. The work was conducted following Good Laboratory Practices guidelines.
Statistical analysis comparing infected and control groups were done using T-test (p<0.05).
Histology. An experiment was conducted to study histological lesions induced by the recombinant viruses. Rainbow trout distributed into 30-fish groups (fish with mean total weight of 4-7 g) in 50 l tanks were intraperitoneally (ip) injected with 100 μl of each of the IHNV recombinants or with wild type IHNV as a positive control group (5x10 6 pfu ml -1 ). A negative control group was injected with culture medium. The evolution of the histological lesions was evaluated on 4 fish from each group at days 1, 3, 7 14 and 28 post-infection. The muscle, kidney, liver, spleen and brain were sampled and processed for histology. The severities of the lesions were recorded using a grading system established for the most frequent kidney and liver lesions (Romero et al. 2005) . injected with 100 μl of either the wild IHNV (positive control group) or the different recombinants (2x10 6 pfu ml -1 ). After 1 and 3 days post-injection, three fish from each group were sampled and the kidney, liver and spleen removed. RNA extraction was performed using Trizol Reagent (Invitrogen) following the manufacturer indications.
The reverse transcription and semi-nested PCR were performed following the procedure described by Miller et al. (1998) .
Immunization and virus challenge. Three trials were performed to study the protection induced by each recombinant virus against experimental challenges with pathogenic IHNV and VHSV. Trout groups (N=80, with a total mean weigh of 5,5 g) were ip inoculated with 100 μl of each recombinant (10 6 pfu ml -1 ). An additional group was mock infected with PBS (negative control group). 30 days after vaccination, fish were ip challenged with 100 μl injection containing 2x10 6 pfu ml -1 of the pathogenic wild type viruses, IHNV or VHSV. Mortalities were recorded 30 days post challenge.
The vaccine efficacy was expressed as the fraction of the mortality that was prevented by the vaccination up to the end of the experiment (Relative Percent of Survival) (RPS = 1 -(% mortality in vaccinated group / % mortality in control group) x 100 (Jarp & Tverdal 1997) . A T-test (p<0.05) was used to compare vaccinated and control results. Antibody production. To determine the ability of the different IHN recombinant viruses to induce antibody production, rainbow trout (mean total weight 22 g) were ip injected with 250 μl solution containing 10 3 pfu ml -1 of each virus. Positive control groups were injected with IHNV or VHSV wild types. A non lethal infection was conducted (low viral dose) to avoid killing the fish but enough to induce the antibody production before the end of the experiment. Blood was drawn from the caudal vein after 4, 7 and 10 weeks of exposure to the viruses and clotted overnight. Plasma was obtained by centrifugation for 15 min at 500 xg in a refrigerated centrifuge, and was stored at -20ºC until antibody production was quantified by an enzyme-linked immunosorbent assay (ELISA) previously described (Romero et al. 2005 ).
For the ELISA, 96 well-plates were coated overnight with IHNV (2x10 6 pfu ml -1 , 50 μl well -1 ) that was diluted in coating buffer (Na 2 CO 3 0.0015 M, NaHCO 3 0.03 M, pH 9.6) at 4ºC. All unbound sites were then blocked with phosphate buffered saline Tween-20 (PBS + 1% Tween-20) with 3% bovine serum albumin (BSA) for 1h at 37ºC.
Plasma dilutions were performed in PBS-T + 1 % BSA and added in duplicate to precoated and blocked ELISA plates. After 1 h of incubation at 37ºC, plates were washed twice with PBS-T and incubated with a polyclonal anti-trout Ig (1G7) (Sánchez et al. 1991 ) diluted 1:500 in PBS-T for 2 h at room temperature, and revealed by a further 1 h incubation with a peroxidase conjugated anti-IgG antibody diluted 1:1000 in PBS. After two TBS-T washes, the enzyme substrate, orthophenylendiamine (OPD) (Sigma) was added and the reaction was stopped 20 min later with the addition of 3M sulphuric acid. The reaction intensity was measured by reading the optical density at 492 nm and the antibody titter was calculated, taking a sample as standard (Shapiro et al., 1997) . The antibody titer was represented as Units per ml. In the case of samples The IFNαβ, and two genes coding for proteins induced by IFNαβ, Mx and an ubiquitin-like protein, ISG-15 expression profile were the same in fish treated with the two wild type viruses. A rapid increase of expression was observed from day 1 to day 2, followed by a decrease at day 3. IHNV induced maximum levels of these genes in the liver, meanwhile VHSV induced them in kidney. Variations were observed in gene expression levels in the negative control group. The GFP recombinant viruses did not induce an increased gene expression neither in the kidney nor in the liver. Although an IFNαβ expression up-regulation was observed in kidney and liver from rIHNV-Gvhsv GFP inoculated fish, they were always lower than those induced by IHNV and VHVS.
The induction levels recorded in rIHNV GFP infected fish were always as low as the levels detected in the negative control group. The UV light induced the highest apoptosis levels at 24 and 48 h (16.5% and 13% of apoptotic cells respectively) in comparison with the negative control group (less than 2%). Cells infected with the apathogenic rIHNV-Gvhsv GFP had low apoptosis levels at 24 h but showed around 13% of apoptosis, similar to UV-treated cells, at 48 h.
It is important to point out that IHNV wild type induced apoptosis levels were significantly lower than those induced by the recombinant virus (less than 5%). The percentage of necrotic cells induced by IHNV was similar to the percentage induced by rIHNV-Gvhsv GFP (around 15%) but lower than the positive control (27%). Using the FL-1 channel, it was possible to detect 5% of cells infected with rIHNV-Gvhsv GFP at 48h post-infection. The apoptosis in cells treated with the UV light and with IHNV was always lower than 0.5 %. IHNV route of entry and progression has been studied in depth (Yamamoto 1990 , Yamamoto & Clermont 1990 , Drolet et al. 1994 suggesting that IHNV infection progressed from gills into the circulatory system and from the oral region into the gastrointestinal tract and circulatory system. Romero et al. (2005) Antibody production is one of the mechanisms involved in the effectiveness of a vaccine. LaPatra et al. (1993) and Lorenzen & LaPatra (1999) showed that rainbow trout can produce specific and highly functional antibodies that are able to neutralise IHNV pathogenicity in vitro as well as in vivo. The kinetics and antibody production following an experimental infection with the recombinant viruses were not similar to those previously described for IHNV. The rIHNV GFP was able to induce specific IHNV antibodies but the titer did not increase with time. As expected, the rIHNVGvhsv GFP was able to stimulate VHSV antibody production but the titer did not increase with time. The highest antibody titer was recorded at the tenth week. As shown in the results, the recombinant viruses did not induce a high antibody production that could explain the values of protection obtained. Probably other immune mechanism may be involved in the protection.
A correlation between high antibody production, high levels of antiviral cytokines expression and protection has been described on several fish vaccination models (Boudinot et al. 1998 , McLauchlan et al. 2003 . Kim et al. (2000) using a DNA vaccine encoding the viral glycoprotein, correlated an early, non-specific antiviral protection with high levels of Mx protein in the kidney and liver, and they proposed that 
